| 000 | 01887 a2200565 4500 | ||
|---|---|---|---|
| 005 | 20250518070558.0 | ||
| 264 | 0 | _c20200901 | |
| 008 | 202009s 0 0 eng d | ||
| 022 | _a1936-086X | ||
| 024 | 7 |
_a10.1021/acsnano.9b07214 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aIbrahim, Mohamed Moustafa | |
| 245 | 0 | 0 |
_aOnce Daily Pregabalin Eye Drops for Management of Glaucoma. _h[electronic resource] |
| 260 |
_bACS nano _c12 2019 |
||
| 300 |
_a13728-13744 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdhesiveness |
| 650 | 0 | 4 | _aAdministration, Topical |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCalcium Channels _xmetabolism |
| 650 | 0 | 4 |
_aCornea _xdrug effects |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Liberation |
| 650 | 0 | 4 |
_aEmulsions _xchemistry |
| 650 | 0 | 4 |
_aGlaucoma _xdrug therapy |
| 650 | 0 | 4 | _aHydrogen-Ion Concentration |
| 650 | 0 | 4 |
_aIntraocular Pressure _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aOils _xchemistry |
| 650 | 0 | 4 |
_aOphthalmic Solutions _xadministration & dosage |
| 650 | 0 | 4 | _aParticle Size |
| 650 | 0 | 4 | _aPermeability |
| 650 | 0 | 4 | _aPhase Transition |
| 650 | 0 | 4 |
_aPregabalin _xadministration & dosage |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 | _aStatic Electricity |
| 650 | 0 | 4 |
_aTissue Distribution _xdrug effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aViscosity |
| 650 | 0 | 4 |
_aWater _xchemistry |
| 650 | 0 | 4 | _aX-Ray Diffraction |
| 700 | 1 | _aMaria, Doaa Nabih | |
| 700 | 1 | _aMishra, Sanjay R | |
| 700 | 1 | _aGuragain, Deepa | |
| 700 | 1 | _aWang, XiangDi | |
| 700 | 1 | _aJablonski, Monica M | |
| 773 | 0 |
_tACS nano _gvol. 13 _gno. 12 _gp. 13728-13744 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/acsnano.9b07214 _zAvailable from publisher's website |
| 999 |
_c30300163 _d30300163 |
||